Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DVL2 |
| Upstream (Parents) |
|---|
| (<<) FAM57A → DVL2 |
| (<<) RPS9 → DVL2 |
| (<<) GEMIN4 → DVL2 |
| (<<) CHD3 → DVL2 |
| (<<) NACA2///NACAP1///NACA → DVL2 |
| Downstream (Children) |
|---|
| DVL2 → PRKCE (>>) |
| DVL2 → RPL5P1///RPL5P34///RPL5 (>>) |
| DVL2 → HBB (>>) |
| DVL2 → HBA2///HBA1 (>>) |
| DVL2 → FAM48A (>>) |
| DVL2 → SERPINB4///SERPINB3 (>>) |
| DVL2 → ZCCHC11 (>>) |
| DVL2 → DKFZP434C153 (>>) |
| DVL2 → NELL1 (>>) |
| DVL2 → ADRA2B (>>) |
